Joel Greenblatt's ZVRA Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 34,791 shares of Zevra Therapeutics, Inc. (ZVRA) worth $381,657, representing 0.00% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in ZVRA, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Zevra Therapeutics (ZVRA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zevra Therapeutics (ZVRA) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +34,791 | New Buy | 34,791 | $10.97 |
Joel Greenblatt's Zevra Therapeutics Investment FAQs
Joel Greenblatt first purchased Zevra Therapeutics, Inc. (ZVRA) in Q3 2026, acquiring 34,791 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Zevra Therapeutics, Inc. (ZVRA) for 1 quarters since Q3 2026.
Joel Greenblatt's largest addition to Zevra Therapeutics, Inc. (ZVRA) was in Q3 2026, adding 34,791 shares worth $381,657.
According to the latest 13F filing for Q3 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 34,791 shares of Zevra Therapeutics, Inc. (ZVRA), valued at approximately $381,657.
As of the Q3 2026 filing, Zevra Therapeutics, Inc. (ZVRA) represents approximately 0.00% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Zevra Therapeutics, Inc. (ZVRA) was 34,791 shares, as reported at the end of Q3 2026.